Search results
Novavax, Inc. (NVAX) vs. Its Peers: A Comparison – News Heater
NewsHeater· 2 days agoThere are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 2 rating it as “overweight,” 5 rating it as “hold,” and 0 rating it as “sell.” The public float for NVAX is 132.98M ...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 5 hours agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 5 hours agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
12 Most Shorted Stocks in 2024
Insider Monkey via Yahoo Finance· 5 days agoIn this article, we will take a detailed look at the 12 Most Shorted Stocks in 2024. For a quick overview of such stocks, read our article 5 Most Shorted...
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
Motley Fool via Yahoo Finance· 4 days agoThat could happen if Amtagvi sales truly take off, showing the potential of TIL technology. But even...
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Zacks via Yahoo Finance· 2 days agoLNTH is just one of a large group of Medical stocks with a positive ESP figure. Novavax (NVAX) is...
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 2 days agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine,...
Less than half of nursing home residents are up to date with their COVID-19 vaccines, study finds:...
Yahoo Life· 2 days agoHere’s your go-to guide with everything you need to know about COVID-19, including testing expanding...
COVID Vaccine Study Finds Small Signal of Seizure Risk in Young Kids
MedPage Today· 19 hours agoData gathered from over 4 million children revealed that myocarditis or pericarditis occurred at...
What's in Store for Biogen (BIIB) This Earnings Season?
Zacks via Yahoo Finance· 5 days agoBiogen's (BIIB) sales in the first quarter are likely to have been hurt by lower sales of its...